Since serum lipid levels are increased in both insulin deficiency and thyroid hypofunction a prospective study of serum lipids, glucose tolerance, and insulin response in patients on phenytoin has been carried out.
mmol/l (181 to 363 mg/100 ml) and 0-43 to 2-0 mmol/l (38 to 177 mg/ 100 ml), respectively. No patient had clinical or latent diabetes. The dose of phenytoin varied from 300 to 450 mg/day. At each examination body weight, fasting serum cholesterol and triglyceride levels, blood glucose, plasma insulin, and serum levels of phenytoin were measured, and a standard 50-g oral glucose tolerance test was performed.
Two patients were lost from the study after three months. In the nine who completed the 12-month schedule the serum phenytoin levels ranged from 10 to 63 vmol/l (2-5 to 15 9 ILg/ml). The patients maintained stable body weights throughout the study, the greatest individual change being an increase of 2 kg. The serum cholesterol levels increased by 6 to 48% (mean 19°.o; P<005) in 9 of the 11 patients during the first three months on phenytoin, the higher level being maintained up to the end of the 12-month period. No Conversion: SI to Traditional Units Cholesterol: 1 mmol/l 38 5 mg/100 ml. Triglyceride: 1 mmol/lz 88-5 mg/100 ml.
Glucose: 1 mmol/lz 18-0 mg/100 ml.
Discussion
The mechanism by which phenytoin increases the serum cholesterol level is obscure but the known pharmacological effects of the drug offer at least two possible explanations. Phenytoin decreases the level of circulating thyroid hormones including free thyroxine and triiodothyronine,2 and the increase in serum cholesterol could be due to subclinical hypothyroidism. Another explanation is based on the phenobarbitone-like effect of phenytoin on hepatic microsomal enzymes. Phenobarbitone stimulates the hepatic synthesis of cholesterol3 and increases the formation and pool size of bile acids,4 which in turn may increase the intestinal absorption of cholesterol by facilitating micelle formation.
An increase in serum cholesterol may be regarded as an untoward effect of long-term phenytoin treatment because it increases the risk of coronary heart disease. We therefore suggest that serum cholesterol should be regularly checked in patients undergoing such treatment.
The lack of deterioration in glucose tolerance may have been due to the relatively small doses of phenytoin used. The mean plasma insulin response to oral glucose also remained unchanged during treatment, though a clear tendency of a diminishing insulin secretion occurred, particularly in patients with high pretreatment levels. This observation agreed with the experience of Stambaugh and Tucker.5 This study was aided by project grant 01190714 from the Finnish Medical Research Council (Academy of Finland). We thank Mrs. SirkkaLiisa Runeberg for technical help. of the right femur. Before admission she was being treated for arthritis with the following: Safapryn six tablets, phenylbutazone' 300 mg, ampicillin' 1 g, and ethylestrenol 2 mg daily and nitrazepam 5 mg nightly.. These, drugs were continued throughout her stay in hospital. An Austi'n-Moore prosthesis was inserted at operation on the right hip. She was recovering satisfactorily until her general condition unexpectedly deteriorated 22 days. after admission and she died 24 hours later.
Necropsy showed peritonitis arising from three:acute.perf.oations of the' stomach. The largest, 1 cm in diameter,. was.in the.,'greater curvature. The others were in the anterior and posterior walls of the pyloru's. There was no pyloric stenosis. The stomach and intestines contai,ed, altered. blood. There were 67 tablets in the stomach. The mucosa of the greater curvature'around the perforation showed multiple erosions, apparently where .tablets were in contact with the mucosa (see fig.) . The heart,. lungs-an.d liver appeared normal. The tablets were all enteric-coated aspirin identical to the inner core of Safapryn. Free aspirin was not foun,d in a sample of stomach contents. Post-mortem blood contained 1-03 mmol/l (156 F.gfml) of.paracetamol, and 363 ,umol/l (50 [±g/ml) of salicylate. No other drtis were detected in the blood or stomach contents.
An overdose of Safapryn tablets was taken, frw, .hich paracetZa,mol was absorbed but little aspirin was releed.N eeless, the local concentration of mucosal irritants at sitesincotact ,wicthotablets seems to be important,' and the gastric erosioWs6ugges that local release of aspirin from some tablets may bhave ,used.theu lceration.
We should be aware that enteric-coated aspirin does not ,ennsure: safety from gastric toxicity.
We thank Dr. L. F. Prescott for advice.
'Heffeman, S. J., and Murphy, J. J., British'MeidicalJournal, 1975 The differential diagnosis of an acute or subacute tender swelling in the calf or popliteal fossa includes thrombophlebitis, dissecting popliteal (Baker's) cyst, gastrocnemius tear, benign neoplasms, and aneurysm. The most difficult and most common differential diagnosis is between thrombophlebitis and dissecting popliteal cyst. We evaluated a simple benign procedure-arthroscintigraphy, using an intra-articular injection of high specific activity9mTc labelled human serum albumin (H.S.A.)-to confirm or refute the diagnosis.
Patients, methods, and results Sixteen patients were studied. Under aseptic conditions 3-5 mCi of S'mTc-H.S.A. in 1-1-5 ml was injected intra-articularly into the affected knee joint. At three and 24 hours the leg was imaged from six inches above the injection site to the ankle, using a five-inch (13 cm) crystal rectilinear scanner. The arthroscintigram showed dissection or rupture of a cyst in six patients.
Eight of the patients had venography and four were shown to have venous thrombosis; in all of these four patients the arthroscintigram was normal. Five patients underwent arthrography. In one patient with a normal arthrogram the arthroscintigram showed an abnormal large popliteal cyst (see fig.) .
The six patients with positive scans included three with symptoms related to athletic activity, two with spontaneous onset of symptoms, and one in whom symptoms were associated with prior rheumatoid arthritis. Because of the strong clinical suspicion of acute thrombophlebitis seven of these patients had been started on heparin one to six days before the scanning procedure. Recently, several reports have described the clinical usefulness of radionuclide arthrography after the intra-articular injection of psuI-H.S.A.3 4 But the preferable physical characteristics of 9p9mTc (140-keV photon emission, six-hour physical half life, and decreased adsorbed radiation dose) make this nuclide a much more desirable radiolabel. Because of these features, millicurie rather than microcurie quantities can be used and, thus, much better resolution images are obtained.
